These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34315901)

  • 1. Functional and epigenetic phenotypes of humans and mice with DNMT3A Overgrowth Syndrome.
    Smith AM; LaValle TA; Shinawi M; Ramakrishnan SM; Abel HJ; Hill CA; Kirkland NM; Rettig MP; Helton NM; Heath SE; Ferraro F; Chen DY; Adak S; Semenkovich CF; Christian DL; Martin JR; Gabel HW; Miller CA; Ley TJ
    Nat Commun; 2021 Jul; 12(1):4549. PubMed ID: 34315901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dnmt3a deficiency in the skin causes focal, canonical DNA hypomethylation and a cellular proliferation phenotype.
    Chen DY; Ferguson IM; Braun KA; Sutton LA; Helton NM; Ramakrishnan SM; Smith AM; Miller CA; Ley TJ
    Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33846253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remethylation of
    Ketkar S; Verdoni AM; Smith AM; Bangert CV; Leight ER; Chen DY; Brune MK; Helton NM; Hoock M; George DR; Fronick C; Fulton RS; Ramakrishnan SM; Chang GS; Petti AA; Spencer DH; Miller CA; Ley TJ
    Proc Natl Acad Sci U S A; 2020 Feb; 117(6):3123-3134. PubMed ID: 31996479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal abnormalities in mice with Dnmt3a missense mutations.
    Bell-Hensley A; Beard DC; Feeney K; Zheng H; Jiang Y; Zhang X; Liu J; Gabel H; McAlinden A
    Bone; 2024 Jun; 183():117085. PubMed ID: 38522809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression.
    Spencer DH; Russler-Germain DA; Ketkar S; Helton NM; Lamprecht TL; Fulton RS; Fronick CC; O'Laughlin M; Heath SE; Shinawi M; Westervelt P; Payton JE; Wartman LD; Welch JS; Wilson RK; Walter MJ; Link DC; DiPersio JF; Ley TJ
    Cell; 2017 Feb; 168(5):801-816.e13. PubMed ID: 28215704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid leukemia sensitize cells to azacytidine via viral mimicry response.
    Scheller M; Ludwig AK; Göllner S; Rohde C; Krämer S; Stäble S; Janssen M; Müller JA; He L; Bäumer N; Arnold C; Gerß J; Schönung M; Thiede C; Niederwieser C; Niederwieser D; Serve H; Berdel WE; Thiem U; Hemmerling I; Leuschner F; Plass C; Schlesner M; Zaugg J; Milsom MD; Trumpp A; Pabst C; Lipka DB; Müller-Tidow C
    Nat Cancer; 2021 May; 2(5):527-544. PubMed ID: 35122024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid and accurate remethylation of DNA in
    Li Y; Abel HJ; Cai M; LaValle TA; Yin T; Helton NM; Smith AM; Miller CA; Ley TJ
    Sci Adv; 2024 Feb; 10(5):eadk8598. PubMed ID: 38295174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth disrupting mutations in epigenetic regulatory molecules are associated with abnormalities of epigenetic aging.
    Jeffries AR; Maroofian R; Salter CG; Chioza BA; Cross HE; Patton MA; Dempster E; Temple IK; Mackay DJG; Rezwan FI; Aksglaede L; Baralle D; Dabir T; Hunter MF; Kamath A; Kumar A; Newbury-Ecob R; Selicorni A; Springer A; Van Maldergem L; Varghese V; Yachelevich N; Tatton-Brown K; Mill J; Crosby AH; Baple EL
    Genome Res; 2019 Jul; 29(7):1057-1066. PubMed ID: 31160375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal hematopoiesis driven by mutated DNMT3A promotes inflammatory bone loss.
    Wang H; Divaris K; Pan B; Li X; Lim JH; Saha G; Barovic M; Giannakou D; Korostoff JM; Bing Y; Sen S; Moss K; Wu D; Beck JD; Ballantyne CM; Natarajan P; North KE; Netea MG; Chavakis T; Hajishengallis G
    Cell; 2024 Jul; 187(14):3690-3711.e19. PubMed ID: 38838669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome.
    Tovy A; Rosas C; Gaikwad AS; Medrano G; Zhang L; Reyes JM; Huang YH; Arakawa T; Kurtz K; Conneely SE; Guzman AG; Aguilar R; Gao A; Chen CW; Kim JJ; Carter MT; Lasa-Aranzasti A; Valenzuela I; Van Maldergem L; Brunetti L; Hicks MJ; Marcogliese AN; Goodell MA; Rau RE
    Haematologica; 2022 Apr; 107(4):887-898. PubMed ID: 34092059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding the genetic and clinical spectrum of Tatton-Brown-Rahman syndrome in a series of 24 French patients.
    Thomas H; Alix T; Renard É; Renaud M; Wourms J; Zuily S; Leheup B; Geneviève D; Dreumont N; Schmitt E; Bronner M; Muller M; Divoux M; Wandzel M; Ravel JM; Dexheimer M; Becker A; Roth V; Willems M; Coubes C; Vieville G; Devillard F; Schaefer É; Baer S; Piton A; Gérard B; Vincent M; Nizon M; Cogné B; Ruaud L; Couque N; Putoux A; Edery P; Lesca G; Chatron N; Till M; Faivre L; Tran-Mau-Them F; Alessandri JL; Lebrun M; Quélin C; Odent S; Dubourg C; David V; Faoucher M; Mignot C; Keren B; Pisan É; Afenjar A; Julia S; Bieth É; Banneau G; Goldenberg A; Husson T; Campion D; Lecoquierre F; Nicolas G; Charbonnier C; De Saint Martin A; Naudion S; Degoutin M; Rondeau S; Michot C; Cormier-Daire V; Oussalah A; Pourié C; Lambert L; Bonnet C
    J Med Genet; 2024 Aug; 61(9):878-885. PubMed ID: 38937076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic Modifiers.
    Glass JL; Hassane D; Wouters BJ; Kunimoto H; Avellino R; Garrett-Bakelman FE; Guryanova OA; Bowman R; Redlich S; Intlekofer AM; Meydan C; Qin T; Fall M; Alonso A; Guzman ML; Valk PJM; Thompson CB; Levine R; Elemento O; Delwel R; Melnick A; Figueroa ME
    Cancer Discov; 2017 Aug; 7(8):868-883. PubMed ID: 28408400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice.
    Scourzic L; Couronné L; Pedersen MT; Della Valle V; Diop M; Mylonas E; Calvo J; Mouly E; Lopez CK; Martin N; Fontenay M; Bender A; Guibert S; Dubreuil P; Dessen P; Droin N; Pflumio F; Weber M; Gaulard P; Helin K; Mercher T; Bernard OA
    Leukemia; 2016 Jun; 30(6):1388-98. PubMed ID: 26876596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-Biased Expansion of DNMT3A-Mutant Clones in a Mosaic Individual Is Associated with Conserved Epigenetic Erosion.
    Tovy A; Reyes JM; Gundry MC; Brunetti L; Lee-Six H; Petljak M; Park HJ; Guzman AG; Rosas C; Jeffries AR; Baple E; Mill J; Crosby AH; Sency V; Xin B; Machado HE; Castillo D; Weitzel JN; Li W; Stratton MR; Campbell PJ; Wang H; Sanders MA; Goodell MA
    Cell Stem Cell; 2020 Aug; 27(2):326-335.e4. PubMed ID: 32673568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Base-Resolution Analysis of DNA Methylation Patterns Downstream of
    Duncan CG; Kondilis-Mangum HD; Grimm SA; Bushel PR; Chrysovergis K; Roberts JD; Tyson FL; Merrick BA; Wade PA
    G3 (Bethesda); 2018 Mar; 8(3):805-813. PubMed ID: 29326230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute myeloid leukemia-associated DNMT3A p.Arg882His mutation in a patient with Tatton-Brown-Rahman overgrowth syndrome as a constitutional mutation.
    Kosaki R; Terashima H; Kubota M; Kosaki K
    Am J Med Genet A; 2017 Jan; 173(1):250-253. PubMed ID: 27991732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by DNMT3A mutational status and associated with predominant hypomethylation of HOX genes.
    Qu Y; Lennartsson A; Gaidzik VI; Deneberg S; Karimi M; Bengtzén S; Höglund M; Bullinger L; Döhner K; Lehmann S
    Epigenetics; 2014 Aug; 9(8):1108-19. PubMed ID: 24866170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic Perturbations by Arg882-Mutated DNMT3A Potentiate Aberrant Stem Cell Gene-Expression Program and Acute Leukemia Development.
    Lu R; Wang P; Parton T; Zhou Y; Chrysovergis K; Rockowitz S; Chen WY; Abdel-Wahab O; Wade PA; Zheng D; Wang GG
    Cancer Cell; 2016 Jul; 30(1):92-107. PubMed ID: 27344947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperation of Dnmt3a R878H with Nras G12D promotes leukemogenesis in knock-in mice: a pilot study.
    Shi X; Yang Y; Shang S; Wu S; Zhang W; Peng L; Huang T; Zhang R; Ren R; Mi J; Wang Y
    BMC Cancer; 2019 Nov; 19(1):1072. PubMed ID: 31703632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediating and maintaining methylation while minimizing mutation: Recent advances on mammalian DNA methyltransferases.
    Cheng X; Blumenthal RM
    Curr Opin Struct Biol; 2022 Aug; 75():102433. PubMed ID: 35914495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.